Anthropic wants to develop its own drugs

Anthropic has unveiled Claude Science, a new AI workbench designed for researchers, as reported by The Verge AI. The platform consolidates disparate tools and datasets into a single environment and can generate figures and visuals. Anthropic framed the launch around AI's potential to speed up scientific discovery and the development of healthcare interventions. The company also noted that a wide range of biotech and pharmaceutical firms are already using Claude. In a more ambitious move, Anthropic stated it intends to develop its own drugs. For developers and solopreneurs building AI workflows, this signals a shift from coding-focused AI to domain-specific scientific applications. The move could create new integration opportunities for AI in drug discovery, clinical research, and data analysis. However, it also raises questions about competition with existing biotech AI tools and the implications of an AI company entering the pharmaceutical space.